Selection of bacterial virulence genes that are specifically induced in host tissues

Science

Volumn 259, Issue 5095, 1993, Pages 686-688

  Mahan, Michael J ^a   Slauch, James M ^a   Mekalanos, John J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; GENE INDUCTION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SPLEEN;

ANIMAL; BETA-GALACTOSIDASE; CHROMOSOMES, BACTERIAL; CLONING, MOLECULAR; GENES, BACTERIAL; MICE; MICE, INBRED BALB C; MUTAGENESIS; RECOMBINANT FUSION PROTEINS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRULENCE;

EID: 0027497926     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.8430319     Document Type: Article

References (28)

1. J. J. Mekalanos, J. Bacteriol. 174, 1 (1992).
2. W. C. McFarland and B. A. Stocker, J. Microbiol. Pathol. 3, 129 (1987).
3. V. L. Miller and J. J. Mekalanos, J. Bacteriol. 170, 2575 (1988).
4. - strain of S. typhimurium, MT168 [DEL2901 (purA874::IS10)].
5. R. Simon, U. Priefer, A Puhler, Biotechnology 1, 784 (1983).
6. A phage P22 lysate grown on the integrated fusion strain was used to transduce a recipient that contains the Pi replication protein, which is required for replication of the plasmid. The transducing phage delivers a linear chromosomal fragment that contains the integrated fusion plasmid. Presumably, once the chromosomal fragment enters the recipient cell, the plasmid circularizes by homologous recombination between the duplicated region defined by the cloned S. typhimurium DNA. The circularized fragment can then replicate as a plasmid in the presence of the Pi replication protein, resulting in the cloned fusion of interest.
7. J. Devereux, P. Haeberli, O. Smithies, Nucleic Acids Res. 12, 387 (1984).
8. J. Piette et al., Proc. Natl. Acad. Sci. U.S.A. 81, 4134 (1984).
9. H. Nyunoya and C. J. Lusty, ibid. 80, 4629 (1983).
10. N. Glandsdorff, in Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology, F. C. Neidhart, Ed. (American Society for Microbiology, Washington, DC, 1987), pp. 321-344
11. P. A. Fields, R. V. Swanson, C. G. Hairdaris, F. Heffron, Proc. Natl. Acad. Sci. U.S.A. 83, 5189 (1986).
12. J. A. Plumbridge and M. Springer, J. Mol. Biol. 144, 595 (1980).
13. Y. Mechulam, G. Fayat, S. Blanquet, J. Bacteriol. 163, 787 (1985).
14. D. I. Friedman, Cell 55, 545 (1988).
15. C. J Dorman and C. F. Higgins, J. Bacteriol. 169, 3840 (1987).
16. R. D. Leunk and R. J. Moon, Infect. Immun. 36, 1168 (1982).
17. H. A. Lockman and R. Curtiss, ibid. 60, 491 (1992).
18. P. H. Mäkelä and B. A. D. Stocker, in Handbook of Endotoxin: Chemistry of Endotoxin, E. T. Rietschel, Ed. (Elsevier, New York, 1984), vol. 1, pp. 59-137.
19. X. M. Jiang, Mol. Microbiol. 5, 695 (1991).
20. N. A. Nnalue and A. A Lindberg, Infect. Immun. 58, 2493 (1990).
21. V. S. Baselski, S. Upchurch, C. D. Parker, ibid. 22, 181 (1978).
22. G. Ivanovics, E. Marjai, A. Dobozy, J. Bacteriol. 85, 147 (1968).
23. H. B. Levine and R. L. Maurer, J. Immunol. 81, 433 (1958).
24. S. C. Straley and P. A. Harmon, Infect. Immun. 45, 649 (1984).
25. B. A. Stocker, Vaccine 6, 141 (1988).
26. 5 cells of an individual fusion strain. Six days after infection, the mice were killed and their spleens were removed. The β-gal activity in each sample was determined by a kinetic assay with the use of the fluorescent substrate fluorescein di-β-o-galactopyranoside (FDG; Molecular Probes, Inc.) and a model SPF-500c spectrofluorometer (SLM Aminco). The units of β-gal were obtained by comparison of the activity to a standard curve.
27. K. T. Hughes and J. R. Roth, Genetics 119, 9 (1988).
28. We thank P. Hanna and J. Tobias for critically reading the manuscript. Supported by National Institutes of Health grant AI26289 (to J.J.M.), National Research Service Award AI08245 (to M.J.M.), and Damon Runyon-Walter Winchell Cancer Research Fund DRG-1016 (to J.M.S.).